Immune Cells in Cancer Therapy and Drug Delivery - Wikidata - thesis-toulmin - TriplyDB

Immune Cells in Cancer Therapy and Drug Delivery

Immune Cells in Cancer Therapy and Drug Delivery

http://www.wikidata.org/entity/Q26747061

about

B-cell populations are expanded in breast cancer patients compared with healthy controls.Salmonella Immunotherapy Improves the Outcome of CHOP Chemotherapy in Non-Hodgkin Lymphoma-Bearing Mice.

P2860

Q48181967-6A30DF1D-E306-45C8-BBE2-5005E4D7C8A0 Q49395392-39535649-204E-44B4-A409-22802E586CD4

P2860

Immune Cells in Cancer Therapy and Drug Delivery

http://www.wikidata.org/entity/Q26747061

description

2016 nî lūn-bûn

@nan

2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Immune Cells in Cancer Therapy and Drug Delivery

@ast

Immune Cells in Cancer Therapy and Drug Delivery

@en

Immune Cells in Cancer Therapy and Drug Delivery

@nl

type

label

Immune Cells in Cancer Therapy and Drug Delivery

@ast

Immune Cells in Cancer Therapy and Drug Delivery

@en

Immune Cells in Cancer Therapy and Drug Delivery

@nl

prefLabel

Immune Cells in Cancer Therapy and Drug Delivery

@ast

Immune Cells in Cancer Therapy and Drug Delivery

@en

Immune Cells in Cancer Therapy and Drug Delivery

@nl

P1433

Q26747061-5FDF9D27-4750-4D41-AE5D-0030D9A4834A

P1476

Q26747061-E043E00F-D9A6-46B8-A715-A7515F396B1A

P2093

Q26747061-23DAE1B0-F155-4176-94A9-6F2BD55AD091

Q26747061-466A1F7D-ECF2-4B01-B12D-324C7D2AE707

Q26747061-4D6C3B6A-1F2B-4AE4-9C3E-066BFE695F23

Q26747061-583765BC-1BEE-4C5C-9632-4B52BAFDF903

Q26747061-82641C91-E228-4707-97E2-499FD9BE310A

Q26747061-A816EE87-91B4-427F-93C1-5586F3663482

Q26747061-B46428DE-6951-4B28-BFE6-467C7B5E8092

Q26747061-B8D89DBD-50EC-4FCC-B262-656AF7A2E649

Q26747061-EB23BA84-6FB7-4509-A93A-44B65A4CCF48

P275

Q26747061-D820BFA8-AAB4-49C5-BB02-0F3E3450193F

P2860

Q26747061-027ABD4B-F20D-4C75-8149-92AB260B781C

Q26747061-02F84F80-B76D-4AF3-981E-D15A391C8DDF

Q26747061-060D6CD7-A12F-4AD0-AF17-7C52E8FA88E0

Q26747061-06D48AE6-EC1F-4889-828E-D4CBEC9F9B5C

Q26747061-08CF3437-43A5-4A54-83A4-2B692AD623CB

Q26747061-08F05000-719C-4141-B5D1-F0E3D41FF26F

Q26747061-093B149F-4E5D-41B5-BD5C-A6E0A075B74D

Q26747061-101A1761-35DD-4DD4-A5F5-8102506A463A

Q26747061-1054A9FE-14B8-4713-B408-801DE7EA4E94

Q26747061-17BED7CA-79BB-4A0E-8E04-094A0F3F9581

P304

Q26747061-5D6D5D9F-0562-4923-B945-06D8BABC6A6C

P31

Q26747061-797981C4-09FB-4B17-B9A3-6515C9C8E0B8

P3181

Q26747061-134A782C-0470-451B-A6C4-B0BA563821E7

P356

Q26747061-D3F254D6-D4E1-46AD-8F92-E44438470673

P407

Q26747061-36224D76-8CAB-4833-BDEB-77F44A6454A1

P478

Q26747061-162C7057-B48A-41A4-963A-34AA8D77A1AD

P50

Q26747061-25541132-6738-4D73-9068-2A1AF50E0B2C

Q26747061-9A36F60C-ABFC-4C88-88E3-305EB629E199

P5008

Q26747061-47FC9AC5-F2D7-4AEA-822A-8538589418AF

P577

Q26747061-2DC62E30-8F36-42EA-9F9E-BF32396C0EEE

P698

Q26747061-C5898BE8-13F6-4C44-9A1C-5DC319E5C084

P921

Q26747061-334FFD07-74AE-4E2E-AA17-AB062911C7A0

Q26747061-5ACCCA4E-173A-45DD-8D1C-6B7E25974E92

Q26747061-B10CF22A-66C3-48E7-8562-709808D73404

P932

Q26747061-42FD0F0F-1DD2-4C48-A468-85BCE67997A8

P3181

P356

P1433

Mediators of Inflammation

P1476

Immune Cells in Cancer Therapy and Drug Delivery

@en

P2093

Alberto Boffi

http://www.w3.org/2001/XMLSchema#string

Bartlomiej Taciak

http://www.w3.org/2001/XMLSchema#string

Joanna Mucha

http://www.w3.org/2001/XMLSchema#string

Katarzyna Tonecka

http://www.w3.org/2001/XMLSchema#string

Katarzyna Ulewicz

http://www.w3.org/2001/XMLSchema#string

Katarzyna Witt

http://www.w3.org/2001/XMLSchema#string

Magdalena Krol

http://www.w3.org/2001/XMLSchema#string

Tomasz P Rygiel

http://www.w3.org/2001/XMLSchema#string

Zofia Pilch

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Killing activity of neutrophils is mediated through activation of proteases by K+ flux

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response

TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

CD200 receptor controls sex-specific TLR7 responses to viral infection

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Antibody therapy of cancer

P304

5230219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2121006

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2016/5230219

http://www.w3.org/2001/XMLSchema#string

P407

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

Kinga Majchrzak

P5008

P577

2016-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27212807

http://www.w3.org/2001/XMLSchema#string

P921

P932

4860248

http://www.w3.org/2001/XMLSchema#string